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The goal of this research was to survey the literature of studies on 
mesothelioma treatments and compare their rates of success. The 
focus was on radiation therapy which is used with chemotherapy or 
surgery treatment for this specific type of cancer. The research is 
based on the chosen treatments of thirteen patients who shared their 
stories on different websites (Table 1). The number of survived years 
for these patients was compared. The results show that the average 
number of years survived in patients who used mind-body therapy is 
greater than other patients who use radiation therapy as palliation 
with chemotherapy, surgery treatment or immune therapy as 
treatment of their disease. The significance of this research was to 
find the best treatment for mesothelioma cancer and find the 
advantage of using radiation therapy as treatment in this specific type 
of cancer. This was done by comparing the rate of patients who 
survived longer with the survey in 1990 (Ball & Cruickshank, 1990). 
 
Introduction 
The definition of cancer is a disease in which abnormally 
developed cells start to divide out of control. Cancer usually is named 
after the type of cell or the organ in which they begin. There is a line 
of cells contained in the abdomen (peritoneum), chest (pleura) and in 
space around heart called the mesothelium. These cells protect organs 
by secreting a special fluid that allows the organs to move. For 
example, this fluid makes it easier for heart to pump outward. 
Malignant mesothelioma has been categorized based on the position 
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of the migrant cells: pleural mesotheliomas, which start in the chest, 
peritoneal mesotheliomas which start in the abdomen, and pericardial 
mesotheliomas which start in the outer layer around heart. 
Additionally, mesothelioma is named based on the shape of the cancer 
when viewed under a microscope. An epithelioid sarcoma is a rare 
mesenchymal soft tissue tumor with an epithelioid pattern (Fanburg-
Smith, Fetsch, Miettinen, Shmookler & Virolainen, 1999). And 
sarcomatoid carcinoma is a relatively uncommon form of cancer 
whose malignant cells have histological, cytological, or molecular 
properties of both epithelial tumors (carcinoma) and mesenchymal 
tumors.  
Thousands of workers and servicemen have become disabled or 
died because of the health effects of asbestos. The expectation is that 
many more will be affected in near future (Craighead & Gibbs, 2008). 
Asbestos fibers are a risk factor of mesothelioma, as they can travel to 
the ends of the small airways and reach the cell lining of the lungs 
during normal breathing. Asbestos fibers are naturally occurring 
minerals. They are resistant to heat and corrosion. They are used in 
products such as insulation for pipes (steam line), floor tiles, building 
materials, and in vehicle brakes and clutches (Craighead & Gibbs, 
2008). 
What is yet to be understood is why mesothelioma is found in 
children as well. Although the average age of diagnosis of 
mesothelioma is sixty-five years, and is usually found in men, it has 
been found in children as well. The risk factor for mesothelioma in 
children has not been identified definitively. Children may also 
experience direct exposure to asbestos in the home. This may occur 
where there are damaged or worn asbestos fibers that have been 
released into the air from old insulation or other old building 
materials. In this situation, the child might inhale the fibers, which 
would then become lodged in the chest or abdominal area, eventually 
leading to the formation of mesothelioma cancer. Children can also 
suffer secondary exposure. This can occur when someone else in their 
Samira Rezaei 
   139 
household works with asbestos – which is rare these days – and brings 
home toxic dust on their clothes or in their hair. The child can breathe 
in these fibers and may eventually get sick because of the exposure to 
the hazardous substance (American Cancer Society, 2013). 
Diagnosis 
Normally, the cancer is diagnosed by an expert who looks at 
samples of cancer, which could be cell or tissue, under microscope. In 
some cases, lab tests of the cell proteins, DNA, and RNA can be used 
for diagnosis as well. There are three ways to diagnose mesothelioma 
cancer.  
Screening such as X-ray, Fluroroscopy, CT 
The standard way of diagnosis is through imaging. X-rays for 
diagnostic procedures or research are produced by accelerating 
electrons using a high voltage and allowing them to collide with a 
metal target (Maniwa, Nishimura, Ohno, Takata & Yoshimura, 2008). 
X-rays are produced when the electrons suddenly decelerate upon 
collision with the metal target. These X-rays are products of what is 
commonly called braking radiation. If the bombarding electrons have 
sufficient energy, they can knock an electron out of an inner shell of 
the target metal atoms. When a metal target is bombarded by high-
energy electrons, X-rays are emitted. An X-ray spectrum typically 
consists of a broad continuous spectrum and a series of sharp lines. 
Where lines are depends on the metal is used. These X-rays are called 
characteristic X-rays.  
There are different imaging modalities: radiography, fluoroscopy, 
computed tomography, nuclear medicine, magnetic resonance 
imaging, and ultrasound.  
In radiography, standard X-ray is used. The radiation will ionize 
and it is the initial screening study of bone, chest, and abdomen for 
mammography. In radiography, air (black), fat (dark gray), 
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water/tissue (gray), bone (light gray), metal (white) appear in different 
colors.  
In fluoroscopy, the real-time X-ray uses ionizing radiation. It is 
utilized for X-ray guided procedures, such as GL studies, 
angio/interventional. Radiography shows the same tissues in the same 
color.  
In computed axial tomography, ionizing radiation is used and the 
computer reconstructs cross-sectional (axial) images. It is the initial 
screening for brain pathology and also for the chest, abdomen and 
pelvis.  
 
MESOMARK 
The MESOMARK assay is one of the most promising diagnostic 
markers for mesothelioma cancer (Alexander, 2006; Hino & Maeda, 
2006 & Hino & Shiomi, 2007). 
In a blood test called the MESOMARK assay, the levels of 
soluble mesthelin-related peptide (SMRP) is measured. SMRP is a 
protein released into the blood by cancerous mesothelioma cells.  
Cancer progresses through a staging system which corresponds to 
the severity of the cancer. This is based on the size and extent of the 
primary tumor and whether or not cancer has spread in the body. 
These stages help the medical doctors to plan appropriate treatment. It 
can be used to deduce a patient’s cancer prognosis. It could also help 
provide a platform for the exchange and comparison of information 
between patients (Ebara et al, 2012). There are different ways to 
determine the stage. Physical exams, imaging studies, laboratory tests, 
pathology and surgical reports are the ways to track the stages of 
cancer. The most widely used cancer staging system is TNM. It is 
based on the size and reach of the primary tumor (T), the amount of 
spread to lymph node (N), and the existence of metastasis (M). Five 
stages are explained in the TNM systems. Usually mesothelioma is 
diagnosed in stage three and four with symptoms. Pleural 
mesothelioma symptoms are characterized by pain in the lower back 
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or at the side of the chest, shortness of breath, cough, fever, sweating, 
tiredness, weight loss, hoarseness, swelling of the face and arms. 
Treatment 
There are different treatments for surviving patients with 
mesothelioma. These include the most used ones, which are radiation 
therapy, surgery, targeted therapy, immune therapy, and 
chemotherapy. In the mesothelioma, radiation therapy is used as a less 
painful alternative. Radioactive particles are used in different ways 
for treatment of this cancer. These are: radiation therapy, 
chemotherapy, and immunotherapy (for high dose chemotherapy).  
Surgery 
Surgery is another option for a person who diagnosed with 
mesothelioma. There are different types of surgery. Curative surgeries 
are used in the early stage of mesothelioma, such as pneumonectomy, 
extra pleural and pleurectomy. Palliative surgeries are another type of 
surgery which is used to relieve mesothelioma symptoms like pain 
and other problems associated with mesothelioma disease, such as 
pleurocentesis, paracentesis, and pleurodesis.  
Targeted Therapy or Molecularly Targeted Therapy 
Molecularly targeted therapy is another option of treatment that 
uses drugs or other substances to identify and attack specific cancer 
cells (National Cancer Institute). This type of therapy has fewer side 
effects than other types. 
Chemotherapy 
Chemotherapy is a type of treatment in which the cancer cells are 
killed. This type of treatment could be useful depending on the stage 
of cancer and where a patient is in treatment process. It could be used 
for curing the cancer, preventing it from spreading, slowing its 
growth, killing cancer cells that may have spread to other parts of 
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body, and relieve the symptoms caused by cancer (American Cancer 
Society.). Many clinical trials have tested the numerous 
chemotherapeutic agents.  The response rate doesn’t exceed more 
than 20% for most of the investigated regimens (Maniwa, Nishimura, 
Ohno, Takata, & Yoshimura, 2008). 
Immune Therapy 
Immune therapy is a type of injection chemotherapy which is 
used for high-dose chemotherapy. In this type of treatment, the body’s 
immune system is used to aid the fight against the cancer. Common 
types of immunotherapy include monoclonal antibodies, cancer 
vaccines, and non-specific immunotherapies. In immunotherapy, 
radioactive materials are placed directly into the chest or the abdomen 
at the site of the cancer. The radiation will move only a very short 
distance, which limits the possible damage to nearby healthy tissues. 
This is the method that is normally used for mesothelioma. 
Radiation Therapy 
Radiation therapy is a treatment in which beams of high-energy 
particles are directed at cancer cells to reduce the potency of 
cancerous cells. There are different types of radiation therapy, but two 
are specifically used in treating mesothelioma. One is called external 
beam radiation therapy (EBRT). In this regimen, the beam source is 
usually on the outside of the patient’s body. A machine is used to 
produce this type of beam. Another type of radiation therapy is 
brachytherapy, in which the radiation source is placed close to the 
surface of the body or within a body cavity. 
In External Beam Radiation Therapy (EBRT), the source of 
radiation may be outside the body of the patient (external radiation 
therapy) or it may be an isotope that has been implanted into 
abnormal tissue or a body cavity. Modern radiation therapy primarily 
uses high-energy X-rays or gamma rays with peak photon energies, 
exceeding 1 mega electron volte. Brachytherapy’s radiation sources 
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are either low energy photon sources (for LDR, or low dose rate 
applications) or high energy photon sources (used for high dose rate 
brachytherapy). Beta brachytherapy is used for intravascular 
brachytherapy for prevention of restenosis and ophthalmic 
applicators).  
Radiation therapy usually is used in two different ways. First, it is 
used to cure cancer. In this way the goal is to destroy tumors that have 
not spread to other body parts and reducing the risk that cancer will 
return after surgery or chemotherapy. Second, radiation therapy is 
used to reduce symptoms. In this way, shrinking tumors will improve 
quality of life. For example, in mesothelioma, the symptoms cause 
shortness of breath. The pain can be alleviated, however, by reducing 
the size of tumors. Radiation is a type of energy in motion. It can be 
in form of fast moving particles of energy waves. There are many 
types of radiation in everyday life such as TV, infrared, visible light, 
UV, X-Rays.  
Atoms are not stable. The excess energy contained in an unstable 
atom is released in the form of a few basic particles and energetic 
waves. Alpha particles are the heaviest particles and are produced 
when the heaviest elements decay.  Beta particles are much lighter 
than alpha particles. Another high energy particle is the gamma ray. It 
is an energetic photon, or light wave, in the same electromagnetic 
family as light and X-rays, but is much more energetic and harmful. 
Gamma rays are also capable of damaging living cells, as they slow 
down by transferring energy to surrounding cell components.  
The major difference between gamma rays and X-rays is that 
gamma rays have more energy. For example, gamma rays have over a 
trillion times more energy than typical radio waves. When gamma 
rays and X-rays interact with the human body, ionization happens, 
because those waves have sufficient energy to dislodge electrons. The 
radiation imparts enough energy to an orbital electron in an atom for 
the electron to free itself. One of the problems with ionization is that 
freed electrons can cause damage to living cells or DNA. If the 
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radiation dose is small, the body can repair itself but a high dose can 
cause biological damage.  
The way ionizing radiation is used to cure cancer is that it 
minimizes the dose to the healthy tissue, while maximizing the dose 
to cancerous tissue. These doses are delivered in small fractions. Such 
doses take advantage of the fact that healthy tissues have better repair 
mechanisms for radiation damage than cancer cells have. A normal, 
self-repairing cell cycle consists of four phases: mitosis, which takes 
one hour, synthesis, which takes six to fifteen hours (depending on 
what kind of cell it is), G2, which takes 3 to 4 hours, and G1, which is 
variable.  
Treatment planning systems contain five steps which are 
positioning, contouring, beam arrangement, optimization and dose 
calculation and display. 
The problem with radiation therapy for mesothelioma is that the 
cancer is in close proximity to the heart and lungs and it is risky to 
provide the kind of high-dose, intensive therapy needed to shrink the 
tumor. IMRT (Intensity-Modulated Radiation Therapy) can more 
accurately target cancer cells and avoid healthy tissue. It may provide 
better results when performed by experienced clinicians.  
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Table 1. Number of Years Patients Survived when Using Different 
Treatments for Mesothelioma. 
        Table 2. Stem Plot - Treatments vs. Years Survived. 
Immune Therapy Surgery Mind-Body Therapy 
12 6 7 
21 4 15
5 10 8 
7
20 
In the research presented above, three different treatments were 
compared (Table 2). These were: immune therapy, surgery, and mind-
body therapy. The averages of the years the patient survived past the 
time the cancer is diagnosed was measured. Averages are shown in 
the following graph. 
Type of  Mesothelioma  
Survived 
Years  Type of Treatment  
Peritoneal Mesothelioma 12 Immune Augmentative Therapy 
Peritoneal Mesothelioma 6 Surgery  and Radiation Therapy
Peritoneal Mesothelioma 21 Antioxidant (melatonin) Immune Therapy  
Peritoneal Mesothelioma 4 Surgery and Radiation Therapy
Peritoneal Mesothelioma 5 Chemotherapy and Radiation Therapy  
Peritoneal Mesothelioma 7 Strict Nutritional Regimen and Mind-Body Therapy 
Peritoneal Mesothelioma 15 Strict Nutritional Regimen  and Mind-Body Therapy 
Peritoneal Mesothelioma 20
Peritoneal Mesothelioma 8 Mind-Body Therapy
Peritoneal Mesothelioma 5 Physical Therapy and Radiation Therapy  
Peritoneal Mesothelioma 10 Surgery and Radiation Therapy
Pleural Mesothelioma 7 Surgery (EPP) and Radiation Therapy 
Pleural Mesothelioma 20 Surgery and Radiation Therapy 
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Figure 1.  Different Treatments vs. Years Survived. 
Figure 1 shows that the average number of years survived in 
patients who used immune therapy is greater than the other patients 
who used surgery and radiation therapy.   
Conclusion 
One of the rarest forms of cancer is mesothelioma. The cancer 
cells are found in pleura or peritoneum (Carbone, Pass & Vogelzang, 
2005). The fact about Mesothelioma is that by the time the symptoms 
appear the disease is often advanced. Regardless of the type of 
treatment, in an advanced situation it is difficult to treat it. According 
to a survey in 1990, the median amount of time the patient survived 
since the time of diagnosis, out of 38 patients, was 9 months, with an 
estimated 2-year survival rate of 16%. Radiation therapy is more 
useful for palliation (Ball & Cruickshank, 1990). This research 
introduced mesothelioma cancer and then further explained the 
different methods of diagnosis. The imaging methods in which 
radiation particles are used were delineated. The different treatments 
for mesothelioma were introduced. Patients who were treated with 
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immune therapy, surgery, and mind body therapy were compared in 
terms of the number of years survived. Also, the advantages and 
practical aspects of radiation therapy were explained.  In summary, 
this research shows that patients who suffered from mesothelioma 
cancer and chose the immune therapy treatment to treat it have 
survived longer in comparison to patients who used other methods of 
treatment.  
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